Log in with your email address username.

×

Attention doctorportal newsletter subscribers,

After December 2018, we will be moving elements from the doctorportal newsletter to MJA InSight newsletter and rebranding it to Insight+. If you’d like to continue to receive a newsletter covering the latest on research and perspectives in the medical industry, please subscribe to the Insight+ newsletter here.

As of January 2019, we will no longer be sending out the doctorportal email newsletter. The final issue of this newsletter will be distributed on 13 December 2018. Articles from this issue will be available to view online until 31 December 2018.

[Correspondence] FreeStyle Libre: contact irritation versus contact allergy

Nesrine Brahimi and colleagues (April 8, p 1396)1 recently expressed their concern on the origin and management of cutaneous adverse events arising from FreeStyle Libre (Abbott Diabetes Care, Witney, Oxfordshire, UK), a sensor-based flash-continuous glucose monitoring system. A study by Bolinder and colleagues (Nov 5, 2016, p 2254)2 indeed reported adverse skin effects when participants were using the device, although participants with a known sensitivity to medical adhesives had been excluded from the trial.

email